Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||UNKNOWN / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Pulmonary embolism
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Dementia; Disease Parkinson''s
Diagnostic Lab Data:
CDC 'Split Type': DEPFIZER INC2021496539
Write-up: Lung embolism/suspected pulmonary embolism; This is a spontaneous report from a non-contactable consumer downloaded from the regulatory authority- DE-PEI-CADR2021059368. Safety Report Unique Identifier- DE-PEI-202100051095. An 86-year-old male patient received the second dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot Number: Unknown) at single dose for covid-19 immunisation. Medical history included Disease Parkinson''s, dementia. The patient''s concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (COMIRNATY) at 0.3ml, single for prophylactic vaccination. The patient experienced lung embolism on an unspecified date. About 4 weeks after the second vaccination with Comirnaty, the patient died with a suspected pulmonary embolism. The patient died on an unspecified date. It was not reported if an autopsy was performed. Source of assessment was PEI. Result was Unclassifiable. No follow-up attempts are possible; information about lot/batch number cannot be obtained. ; Reported Cause(s) of Death: Lung embolism/suspected pulmonary embolism
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166